, Volume 54, Issue 8, pp 2000-2008
Date: 24 May 2011

Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group



The rising prevalence of diabetes worldwide has increased interest in the cost of diabetes. Inpatient costs for all people with diabetes in Scotland were investigated.


The Scottish Care Information—Diabetes Collaboration (SCI-DC), a real-time clinical information system of almost all diagnosed cases of diabetes in Scotland, UK, was linked to data on all hospital admissions for people with diabetes. Inpatient stay costs were estimated using the 2007–2008 Scottish National Tariff. The probability of hospital admission and total annual cost of admissions were estimated in relation to age, sex, type of diabetes, history of vascular admission, HbA1c, creatinine, body mass index and diabetes duration.


In Scotland during 2005–2007, 24,750 people with type 1 and 195,433 people with type 2 diabetes were identified, accounting for approximately 4.3% of the total Scottish population (5.1 million). The estimated total annual cost of admissions for all people diagnosed with type 1 and type 2 diabetes was £26 million and £275 million, respectively, approximately 12% of the total Scottish inpatient expenditure (£2.4 billion). Sex, increasing age, serum creatinine, previous vascular history and HbA1c (the latter differentially in type 1 and type 2) were all associated with likelihood and total annual cost of admission.


Diabetes inpatient expenditure accounted for 12% of the total Scottish inpatient expenditure, whilst people with diabetes account for 4.3% of the population. Of the modifiable risk factors, HbA1c was the most important driver of cost in type 1 diabetes.

The SDRN Epidemiology Group: H. Anwar, J. Chalmers, S. Cunningham, T. deWees, A. Emslie-Smith, C. M. Fischbacher, S. Hynd, A. Judson, J. Kernthaler, G. P. Leese, S. Livingstone, R. McAlpine, M. McGilchrist, S. Philip, F. Sullivan, J. J. Walker